statistiche ricercatore

Continente	#
EU - Europa	1.053
NA - Nord America	987
AS - Asia	815
AF - Africa	72
SA - Sud America	52
OC - Oceania	16
Continente sconosciuto - Info sul continente non disponibili	2
Totale	2.997

Nazione	#
US - Stati Uniti d'America	928
GB - Regno Unito	401
CN - Cina	292
SG - Singapore	183
IT - Italia	170
DE - Germania	127
IN - India	94
SE - Svezia	89
RU - Federazione Russa	57
HK - Hong Kong	54
CA - Canada	52
EG - Egitto	39
FR - Francia	39
IE - Irlanda	37
BR - Brasile	33
IR - Iran	32
TR - Turchia	32
NL - Olanda	27
FI - Finlandia	26
JP - Giappone	26
KR - Corea	23
VN - Vietnam	19
ID - Indonesia	18
AU - Australia	15
CI - Costa d'Avorio	14
BE - Belgio	12
UA - Ucraina	12
DK - Danimarca	10
TN - Tunisia	9
IL - Israele	8
EU - Europa	7
MX - Messico	7
PH - Filippine	7
PL - Polonia	7
TW - Taiwan	7
AR - Argentina	6
CH - Svizzera	6
GR - Grecia	6
AT - Austria	5
IQ - Iraq	5
ES - Italia	4
MA - Marocco	4
EC - Ecuador	3
LT - Lituania	3
PE - Perù	3
PK - Pakistan	3
PY - Paraguay	3
RO - Romania	3
TH - Thailandia	3
VE - Venezuela	3
BD - Bangladesh	2
DZ - Algeria	2
HU - Ungheria	2
IS - Islanda	2
LU - Lussemburgo	2
MY - Malesia	2
PT - Portogallo	2
SK - Slovacchia (Repubblica Slovacca)	2
ZA - Sudafrica	2
AM - Armenia	1
CO - Colombia	1
CZ - Repubblica Ceca	1
ET - Etiopia	1
GE - Georgia	1
LB - Libano	1
LV - Lettonia	1
NG - Nigeria	1
NZ - Nuova Zelanda	1
SA - Arabia Saudita	1
UZ - Uzbekistan	1
Totale	3.002

Nome	#
MELATONIN: A PLEIOTROPIC MOLECULE OF NATURAL ORIGIN. EVALUATION OF THE DIFFERENT THERAPEUTIC ACTIVITIES IN ANIMAL MODELS AND / OR HUMAN PATIENTS AND A STUDY OF THE METABOLIC-BIOCHEMICAL PATHWAYS RELATED TO THEM.	564
Transdermal administration of melatonin coupled to cryopass laser treatment as noninvasive therapy for prostate cancer	336
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction	327
Melatonin : positive effects on high-risk patients with desynchronized sleep-wake rhythm	306
LNCaP Prostate Cancer Growth In Vivo : Oncostatic Effects of Melatonin as compared to Hypoxia and Reoxygenation	279
Different routes and formulations of melatonin in critically ill patients : a pharmacokinetic randomized study	247
Pharmacokinetics of oral melatonin in high-risk critically ill : standard formulation vs incapsulation in solid lipid nanoparticles (SLN)	238
Novel strategies to deliver melatonin (in SLN and by cryo-laser therapy) to prostate cancer cells	235
Novel strategies to deliver melatonin (in SLN and as cryo-laser therapy) to prostate cancer cells in vivo	218
Antitumour activity of melatonin in a mouse model of human prostate cancer : relationship with hypoxia signalling	193
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV	175
Totale	3.118

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	137	0	0	0	0	0	0	11	20	48	14	37	7
2021/2022	225	31	11	22	12	14	21	10	15	24	23	11	31
2022/2023	244	27	38	24	23	18	48	6	16	24	4	7	9
2023/2024	166	17	15	6	13	26	5	12	16	3	11	10	32
2024/2025	365	26	31	9	48	22	8	3	34	32	41	34	77
2025/2026	466	89	43	103	61	74	73	23	0	0	0	0	0
Totale													3.118

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca